Centene will pay $13.7 million to settle more pharmacy benefit management overpayment allegations in Medicaid, this time in New Mexico.
New Mexico Attorney General Hector Balderas' investigation (PDF) focused on concerns that Centene was layering fees and thus not passing discounts on to Centennial Care, the state's Medicaid program. Centene's PBM subsidiaries have serviced Centennial Care members since 2019.
As part of the settlement, Centene agrees to provide complete price transparency on pharmaceutical benefits and services provided to the state.
Comments